Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: StocksDATsoar who wrote (61982)	9/6/2000 9:40:48 AM
From: The Osprey	Read Replies (1) \| Respond to of 150070

Just saw 100,000 cross at 1.70 on OEL on the CDNX....Was that you 200MPH??????.Keep your eyes on it.

To: StocksDATsoar who wrote (61982)	9/6/2000 10:29:46 AM
From: Aerobleu	Read Replies (1) \| Respond to of 150070

DNAP - News --DNAPrint genomics, Inc. Invited to Present at Genomic Partnering Conference, San Francisco September 6, 2000 10:14 AM Eastern Time SARASOTA, Fla.--(BUSINESS WIRE)--Sept. 6, 2000--DNAPrint genomics, Inc., , a Sarasota, Florida based genomics company, announced today that it has been invited to present at the Genomic Partnering Conference, March 3rd-4th, 2001, in San Francisco, California. The conference, which showcases the emerging companies in the genomics field, is sponsored by the Cambridge Healthtech Institute and serves as a forum through which companies engaged in cutting-edge genomics research can continue to grow through partnership. At the conference, Dr. Tony Frudakis and Dr. MyungHo Kim will present data outlining DNAPrint's geometric modeling approach to genetic pattern discovery, as well as outline accomplishments related to the construction of DNAPrint's high-resolution SNP and Haplotype maps, software algorithms and pharmacogenomics knowledge base. About DNAPrint genomics DNAPrint genomics, Inc. provides practitioners of genomic research and personalized medicine with a comprehensive system for complex trait dissection and patient classification. DNAPrint genomics Inc. was founded by a group of scientists with research and commercial experience in high-level mathematical modeling, programming and molecular genetics. For more information about the company, please visit www.dnaprint.com. Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties. The Company's actual results could differ materially from those contained in such statements. Factors that could cause or contribute to such differences include unexpected shortages of critical components, rescheduling or cancellation of customer orders, the timing and market acceptance of new product introductions by the Company and its competitors, and general competition and price pressures in the marketplace. CONTACT: DNAPrint genomics, Inc., Sarasota For scientific inquiries please contact: Dr. Tony Frudakis, 941/351-4543 or All other inquiries please contact: Richard Craig Hall, 941/341-0136